In addition, EZH2 was reported to be upregulated in IPF patients and in bleomycin‐induced lung fibrosis mouse models, and its inhibition following lung injury has been shown to attenuate fibrosis.9 Here, EZH2 is linked to idiopathic pulmonary fibrosis.